Disclosure of Voting results of AGM (Clause 35A)
Cadila Healthcare Ltd has informed BSE regarding the details of Voting results at 20th the Annual General Meeting (AGM) of the Company held on August 12, 2015, under Clause 35A.14-08-2015
14-08-2015
Results of E-Voting and Poll conducted at A G M
Cadila Healthcare Ltd has submitted to BSE a copy of the consolidated Results of E-Voting and Poll conducted at the 20th Annual General Meeting of the Company along with Scrutinizer's Report.14-08-2015
Cadila Healthcare posts 47% rise in Q1 profit
Cadila Healthcare posted a 47% rise in consolidated net profit at Rs.353 crore for the quarter12-08-2015
Results Press Release
Cadila Healthcare Ltd has submitted to BSE a copy of Results Press Release for the period ended June 30, 2015.12-08-2015
Board approves Sub-division of equity shares
Cadila Healthcare Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2015, has considered and approved the sub-division (split) of one equity share of the Company having a face value of Rs. 5/- into five equity shares of face of Rs. 1/- each.The sub-division of shares will be subject to approval by the shareholders, which will be sought by postal ballot, and any other statutory and regulatory...12-08-2015
Announces Q1 results & Limited Review Report for the Quarter ended June 30, 2015
Cadila Healthcare Ltd has announced the following results for the quarter ended June 30, 2015 :The Un-Audited Standalone results for the Quarter ended June 30, 2015: The Company has posted a net profit of Rs. 5557.50 million for the quarter ended June 30, 2015 as compared to Rs. 1972.90 million for the quarter ended June 30, 2014. Total Income has increased from Rs. 11291.30 million for the quarter ended June 30, 2014 to Rs. 19299.30 million for the quarter ended June 30, 2015....12-08-2015
Zydus receives final approval for Amiloride Hcl Tablets
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated August 11, 2015 titled "Zydus receives final approval for Amiloride Hcl Tablets".11-08-2015
Q1 results on August 12, 2015
Cadila Healthcare Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 12, 2015, inter alia, to consider & approve the unaudited financial results for the quarter ended on June 30, 2015 (Q1).Further, as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed from August 03,...24-07-2015
Cut-off Date for E-voting
Cadila Healthcare Ltd has informed BSE regarding "Cut-off Date for E-voting".17-07-2015
AGM on August 12, 2015
Cadila Healthcare Ltd has informed BSE that the 20th Annual General Meeting (AGM) of the Company will be held on August 12, 2015.16-07-2015